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Objective: The primary aim of this study was to determine the impact of obesity in predicting short and
long-term pain relief and functional recovery in total joint arthroplasty (TJA) either as an independent
risk factor or a factor mediated by two chronic conditions associated with obesity-cardiac disease and
diabetes mellitus.
Method: A prospective observational study of 520 patients with primary joint arthroplasties. Pain and
functional outcomes were evaluated with the Western Ontario and McMaster Universities (WOMAC)
Osteoarthritis Index within a month of surgery and then 6 months and 3 years post-operatively. Obesity,
cardiac disease and diabetes mellitus were examined as potential risk factors for poor recovery. Patients
were classiﬁed into four groups based on body mass index (BMI): (normal< 25.0 kg/m2; overweight
25.0e29.9 kg/m2; obese Class 1 30.0e34.9 kg/m2; severe obese Class 2&3 35.0  kg/m2). Linear mixed
models for each joint type (hip and knee arthroplasty) were developed to examine the pattern of recovery
and the effect of obesity.
Results: Ninety-nine (19%) patients were severely obese, 127 (24%) had cardiac disease and 58 (11%) had
diabetes mellitus. Baseline pain and functional scores were similar regardless of BMI classiﬁcation. Severe
obesity was a signiﬁcant risk factor for worse pain and functional recovery at 6 months but no longer at
3 years following total hip and knee arthroplasty. Cardiac disease predicted a slower recovery after hip
arthroplasty. No signiﬁcant interactions existed between obesity and cardiac disease or diabetes mellitus.
Discussion: Severe obesity is an independent risk factor for slow recovery over 3 years for both hip and
knee arthroplasties.
 2012 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Obesity is well recognized as a risk factor for many diseases
including osteoarthritis (OA)1e4. Although the mechanisms of joint
degeneration are not fully understood, mechanical and metabolic
pathways are most likely involved in the development of OA3,5.
Apart from OA, obesity facilitates a number of other secondary
pathologies including cardiac disease, diabetes mellitus, hyper-
tension, and dyslipidemia which, in turn, heightens the complex-
ities of these conditions2. Obesity has a deleterious impact on
health and mobility2,6 and is associated with higher surgical
complications7, mortality8,9, and signiﬁcant healthcare costs10.C.A. Jones, Rm 2-50 Corbett
onton, AB, Canada T6G 2G4.
s Research Society International. PAs obesity is a risk factor for OA, it results in higher risk of total
hip or knee arthroplasty (THA, TKA)11e13. The role of obesity as an
independent risk factor for outcomes of total joint arthroplasty
(TJA) has been ambiguous. While some have reported no difference
in pain and functional outcomes14,15, complications and revi-
sions16,17, others have reported differences18e24. Studies reporting
differences found that patients who are obese tend to be younger,
have more surgically-related complications and require revisions
for septic loosening and dislocation. The presence of cardiac disease
and diabetes mellitus in obese patients with TKA has also been
associated with longer length of stay19.
The projected increase of obesity in the general population will
have ramiﬁcations on obesity-related conditions, in particular OA
and elective surgery such as TJA. The literature remains inconclusive
as to whether obesity is an independent determinant of recovery
after THA and TKA, apart from its association with chronic diseases.
The primary aim of this studywas to determine the impact of obesity
in predicting short and long-term pain relief and functional recoveryublished by Elsevier Ltd. All rights reserved.
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mediated by two chronic conditions associated with obesity, cardiac
disease and diabetes mellitus. Better deﬁning the role of obesitymay
have direct clinical importance when screening for suitable surgical
candidates and proposing pre-operative management for this
potentially modiﬁable condition.
Patients and methods
This prospective observational investigation consisted of
a consecutive cohort of patients placed on a Canadian health
region’s joint replacement waiting list from December 18, 1995 to
January 24, 1997. The study cohort had been assembled for another
study examining waiting list times25. When patients’ names were
entered onto the health region’s waiting list, the research assistant
phoned for recruitment. These patients were assessed within
a month prior to surgery, followed at 6 months and 3 years after
surgery. Inclusion criteria for this study consisted of patients
(1) 40 years or older, (2) scheduled for either a primary THA or TKA,
(3) residing within the health region, and (4) who were placed on
the region’s joint replacement waiting list for at least 7 days before
their surgery. Patients undergoing hemiarthroplasties, revisions,
emergency arthroplasties or residing in long-term care institutions
were excluded. The study protocol was reviewed and approved by
the University of Alberta Health Research Ethics Board.
Upon agreement, in-person interviews were completed within
a month prior to surgery and 6-month post-operatively. Six-month
follow-up was scheduled because the majority of improvement
occurs during this time period. At the 3-year follow-up participants
were contacted by telephone for the interview session.
All 26 orthopedic surgeons who were practicing at either one of
the two hospitals within the health region gave permission for their
patients to be contacted for participation in the study. The average
years of practice for surgeons was 25 years, with 80% having at least
15 years of experience. Surgeons typically used cementless ﬁxation
with strong healthy bone and rigid immediate ﬁxation26. Age,
general health, and activity level were other considerations in
determining the type of implant ﬁxation. An equal proportion of
surgeries was performed at each hospital. No simultaneous bilat-
eral joint surgeries were performed during this study period.
Clinical pathways for THA and TKA were used in the health
region for medical, pharmaceutical and rehabilitation care. All
patients were managed with the same peri-operative regimen that
included the administration of prophylactic antibiotics.
The protocol for physical therapy consisted of commencing mobi-
lization exercises on post-operative day 1. Ambulation by physical
therapists was started after post-operative day one with weight-
bearing as tolerated, unless otherwise stated. If the patient had
a bone graft or an intra-operative complication, weight-bearing
was typically restricted up to 6 weeks post-operatively. Patients
were discharged home with a home exercise program and referral
to community therapy as required.
Standardized medical chart reviews were completed by two
health professionals. Hospital admission height and weight were
extracted from the chart. Surgical and peri-operative information
regarding the implant ﬁxation (cemented, hybrid or cementless), the
number and type of in-hospital complications (wound infection,
dislocation, manipulation under anesthesia, cardio-respiratory,
peripheral/central nervous system involvement, urinary infection,
acute confusion, blood loss requiring transfusion after surgery), and
other medical information such as diagnosis were extracted from
medical charts. Health services utilization data over the 6 months
after discharge were extracted from the regional health databases.
This data included length of stay and readmission to hospitals within
the health region.Measures
The primary outcome variable, joint-speciﬁc pain and function
were measured using the Western Ontario and McMaster Univer-
sities (WOMAC) Osteoarthritis Index27. This self-administered
health questionnaire is designed to measure disability of the
osteoarthritic hip and knee. The WOMAC yields aggregate scores
for joint-speciﬁc pain (ﬁve items), stiffness (two items) and phys-
ical function (17 items). Each item uses a ﬁve point Likert scale. The
range of subscale scores were transformed to one hundred points,
with a score of 0 indicating no pain or dysfunction. We used the
minimal clinically important difference (MCID) for the subscales of
the WOMAC reported by others for patients with TJA. These values
are in excess of 25 points based on a 100 point scale for THA and 19
points for TKA28,29 and were viewed as a guideline for change at an
individual level. The derived MCID should carefully be considered
because the values are dependent upon a number of features such
as the study setting, methodology used to derive the values,
baseline scores and severity of the disease30.
Deﬁnitions of obesity have varied widely and no standard
deﬁnition exists31,32. We used body mass index (BMI) classiﬁcation
(BMI ¼ kg/m2) as deﬁned by the World Health Organization:
underweight (<18.5 kg/m2), normal (18.5e24.9 kg/m2), overweight
(25.0e29.9 kg/m2), and obesity Class 1 (30.0e34.9 kg/m2), Class
2 (35.0e39.9 kg/m2) and Class 3 (40.0 kg/m2). Because of the
small sample of Classes 2&3 for THA, these two groups were clas-
siﬁed as a single group in the analysis and designated as severe
obesity.
Comorbidities such as cardiac disease and diabetes mellitus
were collected (1) from the participant at the baseline interview
and (2) from the medical chart using those medical conditions
listed on admission. The 23 items listed in the Charlson Comor-
bidity Index were used for identiﬁcation of comorbidities33.
Analyses
Because the recovery after THA and TKA differ34, separate models
were developed for each joint. Independent variables were catego-
rized into three sets: (1) demographic variables (age, gender, and
education), (2)medical/baseline variables (diagnosis, BMI, number of
comorbid conditions, cardiac disease, diabetes mellitus, previous
joint arthroplasty, pre-operative ambulatory status, type of residence
and living arrangements), and (3) peri-operative variables (the
number of in-hospital complications, type of implant ﬁxation,
surgeon volume, waiting times, and length of stay). Bivariate anal-
yses for each of these variables were examined on the dependent
variables, WOMAC pain and function scores. All independent vari-
ables that met a statistical level of less than 0.25 in the bivariate
analysis or were considered to be clinically meaningful were
examined in the multivariate analysis. An ample statistical level was
set for the preliminary analyses as not to exclude any variables that
may become signiﬁcant in the regression models.
Linear mixed (LM) modeling was used to examine the pattern of
recovery for WOMAC pain and function scores over the three time
points because non-linear equations provided the best ﬁt for pre-
dicting pain and function scores over the 3 years. Another feature of
the LM modeling allowed us to use available data at each time
period unlike repeated measures analysis that requires complete
datasets over all time periods. Within this model, time, BMI, dia-
betes mellitus, cardiac disease and gender were treated as ﬁxed
effects where the ﬁxed effects describe the mean change in the
population. The LMmodels include parameters that estimate either
pain or function for either THA or TKA before surgery and the rate of
change during the recovery. The square of time is also included as
an estimate of change in the recovery rate because of quadratic
Table I
Patient characteristics
Characteristics n THA n TKA
Demographics 231 289
Mean age, (years)
(mean  SD)
68.2  10.9 69.4  9.2
Gender: female 138 (60%) 170 (59%)
Education: completed
high school
145 (63%) 152 (53%)
Living alone 64 (28%) 70 (24%)
Medical status
Primary diagnosis 225 282
OA 211 (94%) 266 (94%)
Inﬂammatory arthritis 14 (6%) 16 (6%)
Other conditions
Diabetes mellitus 21 (9%) 37 (13%)
Cardiac disease 58 (25%) 69 (24%)
Previous contralateral
arthroplasty
231 79 (34%) 285 83 (29%)
Comorbid conditions
(mean  SD)
231 3.4  2.2 284 3.5  2.0
Health services utilization
Hospital LOS (days)
(mean  SD)
229 7.4  4.9 283 6.9  2.6
Discharge directly home 226 132 (58%) 282 161 (57%)
Rehabilitation facility LOS
(days) (mean  SD)
74 9.1  3.2 100 9.4  3.4
Surgical
Implant ﬁxation 226 282
Cementless 81 (36%) 42 (15%)
Hybrid* 137 (61%) 166 (59%)
Cemented 8 (3%) 74 (26%)
In-hospital complications 227 72 (32%) 282 91 (32%)
* The proximal component is cementless and the distal component is cemented.
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model had two levels which consisted of one level for the within-
individual change over time and the other for between-individual
differences in change over time.
Statistical analyses were done using STATA version 11 and SPSS
version 19.0. A P value of less than 0.05 was considered for statis-
tical signiﬁcance for main level factors and a P value of less than
0.10 for interaction terms. All statistical testing was performedwith
two-tailed tests.Results
Among the 520 participants, 231 received THA and 289 received
TKAwhowere followed over 3 years. The mean age of the cohort at
surgery was 68.9 years (SD 10.0) and 308 (59%) were female. Over
the 3 years, 27% (n ¼ 143) participants were lost to follow-up
including death; no systematic differences between participants
and those lost to follow-up in terms of .age, gender, type of joint
replaced, BMI, diabetes mellitus, cardiac disease, in-hospital
complications, the number of comorbid conditions or baseline
joint pain scores. Participants lost to follow-up did have greater
joint dysfunction at baseline (mean 62.0; SD 16.5) than those fol-
lowed over the 3 years (mean 58.1; SD 16.0) (P ¼ 0.005).Table II
Distribution of cardiac disease and diabetes mellitus over the ﬁve BMI groups
BMI categories THA (n ¼ 231)
<25.0
kg/m2
25.0e29.9
kg/m2
30.0e34.9
kg/m2
35.0e39.9
kg/m2
4
kg
n 52 (22.5%) 88 (38.1%) 59 (25.5%) 23 (10.0%) 9 (
Cardiac disease 58 13 21 17 7 0
Diabetes mellitus 21 3 5 10 1 2Table I presents the demographic, medical and surgical char-
acteristics for each type of joint replaced. As shown in Table II, 52
(23%) of participants with THA and 36 (13%) of participants with
TKA had BMI less than 25.0 kg/m2. The mean BMI for participants
with THA was 29.2 (SD 5.4) kg/m2 and 31.4 (SD 5.7) kg/m2 for TKA.
Cardiac disease was reported in 24% (n ¼ 127) of participants of
which 19 (15%) had BMI  35.0 kg/m2. Diabetes mellitus was
reported in 13% (n¼ 37) of participants with TKA and 9% (n¼ 21) of
the THA group. Slightly more than one-quarter (27.6%) of partici-
pants with diabetes mellitus had BMI  35.0 kg/m2.
The majority of THA prostheses were hybrid (61%) which char-
acteristically consists of a cementless acetabular component and
a cemented femoral stem. A Hardinge lateral approach was used for
80% (n ¼ 181) of hip procedures, while a posterior approach was
used for the remaining (n ¼ 43). Of the TKA, 166 (59%) were hybrid,
74 (26%) were cemented, and 42 (15%) were cementless. The hybrid
prosthesis routinely involved a porous coated femoral component
and a cemented tibial component. Thirty-one percent (n ¼ 87) of
patellae were resurfaced and all of these components were non-
metal backed.
Among the study cohort, 68% (n ¼ 346) of patients had no in-
hospital complications; the incidence of in-hospital complications
was similar for both joint arthroplasty groups, 0.32 per patient. The
most frequently cited complications were urinary tract infection
(n ¼ 31), and then thrombi/emboli (n ¼ 18). There were three
deaths in the TKA group over the 6-month follow-up: two due to
pulmonary embolismwithin 1 month of surgery and the other due
to a non-surgery related cause. Another seven deaths among the
THA group occurred during the 3 years related primarily to
cardiovascular and respiratory causes. Within the 6 months after
surgery, one hip revision was performed for recurrent dislocation
and another 12 participants were seen in emergency departments
within the health region for prosthetic-related reasons. Over the
3 years, six THA and 13 TKA required revisions. The average BMI at
time of primary replacement (30.8 [SD 5.4] kg/m2) did not differ
from the BMI at revision (30.6 [SD 4.8] kg/m2) (P ¼ 0.69).
Severe obese participants (35.0 kg/m2) who received THA
were younger (mean 62.7 [SD 8.6] years) than non-obese partici-
pants (mean 68.5 [SD 11.2] years) (P ¼ 0.02). No signiﬁcant differ-
ences were seen among the different BMI classes regardless of joint
replaced, the number of in-hospital complications, back pain,
contra/ipsi-lateral joint involvement, discharge location from acute
care, and length of stay.
The mean WOMAC pain and function scores for participants are
shown in Table III. No signiﬁcant baseline differences were seen
between any of the BMI groups (P > 0.05) except for pain scores of
TKA (P ¼ 0.03). Participants with BMI 35.0 kg/m2 had signiﬁ-
cantly higher pain scores than those with BMI< 30.0 kg/m2. The
pattern of recovery for both joint pain and function over the 3 years
showed the greatest gain within the ﬁrst 6 months with smaller
improvements seen at 3 years. At 6 months, the mean pain scores
for THA and TKA improved from 31 to 45% from baseline with
smaller changes seen between 6 months and 3 years. Functional
improvement ranged from 25 to 43% at 6 months with smallerTKA (n ¼ 289)
0.0
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C.A. Jones et al. / Osteoarthritis and Cartilage 20 (2012) 511e518514gains seen between 6 months and 3 years. The BMI 35.0 kg/m2
group did not achieve similar pain or function scores at 6 months
except the pain scores for TKA in spite of this group having greater
pain at baseline. While differences were seen at 6 months, no
signiﬁcant differences were seen among the BMI groups at 3 years.
The change in pain and function between baseline and 3-year
WOMAC scores are shown in Table IV. Sixty-eight percent of
participants with BMI  35.0 kg/m2 attained a minimal clinical
difference in functional improvement as compared to 84% of
participants with BMI < 25 kg/m2. Recovery pattern of pain and
function according to BMI groups are shown in Fig. 1 for diabetes
mellitus and cardiac disease. These graphs were not adjusted for
covariates such as age and gender.
Non-linear equations provided the best ﬁt for predicting pain
and function scores over time. Table V provides the estimated
regression coefﬁcients. The intercepts, representing average scores
at the baseline, and the slopes, representing average rates of change
of scores, were random; that is they varied between patients. These
random intercepts and slopes represent between-subject variation
of patient’s scores while the non-linear parts of the equations
suggest that the rate of change of scores over time is not constant
within individuals.
Inﬂuence of obesity was examined in the trajectories ﬁtted for
pain and function data after controlling for age, gender, diabetes
mellitus and cardiac disease. There was signiﬁcant association
between both pain and function scores and BMI  35.0 kg/m2 in
THA patients suggesting that severely obese patients had a slower
recovery for pain and function. However, for TKA, BMI 35.0 kg/m2
had a signiﬁcant association with function scores but borderline
signiﬁcance (P ¼ 0.06) with pain scores. Cardiac disease was
signiﬁcantly associated with pain and function in THA patients. In
addition, among TKA patients, the rate of change over time for pain
and function scores was signiﬁcantly greater in males than in
females, and in non-diabetic than in diabetic patients.
The presence of cardiac disease prior to surgery for patients
with THA predicted a slower recovery, yet no interaction existed
between obesity and cardiac disease when predicting pain or
functional recovery. Diabetes mellitus was not a signiﬁcant inde-
pendent factor of recovery for THA. However, the signiﬁcant
interaction between diabetes mellitus and time for TKA suggests
that rate of change over time for pain and function was different in
diabetics compared to non-diabetics. In other words, pain and
function scores continuously decreasing after 6 months to 3 years
among non-diabetic patients but slightly increased after 6 months
among diabetics. No signiﬁcant interactions were detected among
obesity, diabetes mellitus and cardiac disease.
Discussion
Findings from this community-based cohort conﬁrm that severe
obesity (BMI  35.0 kg/m2) is an independent risk factor for
recovery of pain and functional recovery after TJA. The effect of
weight was only seenwith severe obesity, that is, BMI 35.0 kg/m2.
The pattern of pain relief and functional recovery over the 3 years
for those severely obese patients was slower yet similar scoreswere
reached at 3 years. A smaller proportion of participants with severe
obesity than other BMI groups, however, achieved clinical func-
tional improvement at 3 years. Cardiac disease was an independent
risk factor for poorer joint pain and function, but only for patients
with THA. Inasmuch as obesity is a risk factor for cardiac disease
and diabetes mellitus, no interactions were seen between weight
and cardiac disease or diabetes mellitus in explaining recovery of
pain and function after TJA.
Several recent studies have examined the effect of obesity of TJA
on pain and functional outcomes35e37. While some authors have
Table IV
Change in WOMAC scores between baseline and 3 years for each BMI category
<25.0 kg/m2 (n ¼ 62) 25.0e29.9 kg/m2 (n ¼ 129) 30.0e34.9 kg/m2 (n ¼ 111) 35.0 kg/m2 (n ¼ 74)
WOMAC pain
Mean (95% CI)
difference*
42.8 (37.6, 48.0) 39.1 (35.5, 42.8) 40.8 (36.7, 44.9) 38.7 (33.3, 44.1)
MCID attained,
n(%)
53 (85) 101 (78) 87 (78) 59 (80)
WOMAC function
Mean (95% CI)
difference*
39.1 (34.0, 44.2) 33.0 (29.4, 36.7) 31.7 (27.7, 35.7) 31.3 (25.4, 37.1)
MCID attained,
n(%)
52 (84) 95 (74) 80 (72) 50 (68)
* A positive difference indicates an improvement for the WOMAC score.
C.A. Jones et al. / Osteoarthritis and Cartilage 20 (2012) 511e518 515reported no pain or functional differences between non-obese and
obese patients over the short and long-term follow-up20,38e40,
others have reported that patients with severe obesity had greater
dysfunction and pain post-operatively than other patients24,36,37.
Unlike others who reported poorer pre-operative scores with obese
patients41, our cohort had similar baseline pain and function scores;
the exception being that severe obese patients with TKA reported
greater pain at baseline than the other BMI groups.
We did not ﬁnd that BMI inﬂuenced in-hospital complications
which was congruent with other ﬁndings38,42. Other evidence
suggests that obese patients may have higher hip dislocation rates
after THA22, higher rate of early wound complications18,23,43 andFig. 1. Mean (unadjusted) WOMAC scores for TJA over the three time periods (T1 ¼within a m
BMI groups (<30.0 kg/m2; 30.0e34.9 kg/m2; 35.0 kg/m2). Error bars indicate 95% CIs. Those
and without diabetes mellitus (upper left graph) and cardiac disease (lower left graph). (B)
graph) and cardiac disease (lower right graph).deep vein thrombosis (DVT)44. It may be likely that surgeons within
this community referred only those patients for TJA who were
deemed surgically robust. Similarly, complications not requiring
hospital admission but were treated in the community were not
captured in this cohort and may have accounted for differences.
Cardiac disease is the leading cause of morbidity and mortality
in persons with OA45. Obesity and diabetes mellitus are reported to
be independent factors of cardiac disease46, although the etiologic
mediators are probably multifactorial. The effect of associated
medical factors that are known to be associated with obesity such
as cardiac disease47 and diabetes mellitus48 were included in
our models. Our ﬁndings suggest that cardiac disease was anonth before surgery; T2 ¼ 6 months after surgery; T3 ¼ 3 years after surgery) for three
error bars if negative were truncated at zero. (A) WOMAC pain scores for patients with
WOMAC function scores for patients with and without diabetes mellitus (upper right
Table V
Description of trajectories from random effects models ﬁtted for WOMAC pain and function scores
Factors THA TKA
WOMAC pain WOMAC function WOMAC pain WOMAC function
Coeff (95% CI) P-value Coeff (95% CI) P-value Coeff (95% CI) P-value Coeff (95% CI) P-value
Intercept*, y 57.5 (46.9, 68.1) <0.001 49.0 (38.4, 59.7) <0.001 67.9 (55.3, 80.6) <0.001 60.3 (47.3, 73.3) <0.001
Time 8.15 (8.66, 7.63)z <0.001 7.36 (7.87, 6.85)y <0.001 6.35 (6.83, 5.88)y <0.001 5.39 (5.83, 4.95)y <0.001
Time-squarez 0.19 (0.18, 0.21) <0.001 0.17 (0.16, 0.19) <0.001 0.15 (0.14, 0.16) <0.001 0.13 (0.12, 0.14) <0.001
BMI 30.0e34.9
kg/m2z, x
0.80 (4.57, 2.96) 0.675 2.11 (1.68, 5.90) 0.274 0.42 (3.30, 4.13) 0.825 0.67 (3.15, 4.49) 0.731
BMI  35.0
kg/m2 y, z
5.91 (1.19, 10.64) 0.014 8.07 (3.30, 12.83) <0.001 4.01 (0.15, 8.17) 0.059 5.06 (0.79, 9.34) 0.020
Diabetes mellitusz 2.15 (3.37, 7.68) 0.444 2.51 (8.08, 3.06) 0.375 0.27 (5.00, 5.53) 0.921 0.96 (4.31, 6.22) 0.721
Cardiac diseasez 4.71 (0.97, 8.44) 0.014 4.81 (1.05, 8.57) 0.012 1.61 (2.18, 5.40) 0.404 1.17 (2.72, 5.06) 0.591
Femalez 2.58 (0.66, 5.82) 0.118 2.30 (0.96, 5.56) 0.166 7.67 (11.29, 4.05) <0.001 7.44 (3.82, 11.07) <0.001
Agez 0.06 (0.21, 0.10) 0.470 0.13 (0.3, 0.28) 0.104 0.25 (0.42, 0.07) 0.007 0.13 (0.31, 0.05) 0.165
Diabetes
mellitus  timez
e e 0.25 (0.04, 0.46) 0.022 0.18 (0.2, 0.39) 0.086
Gender  timez e e 0.15 (0.002, 0.30) 0.046 0.21 (0.07, 0.36) 0.005
Variance estimates
Within patient
residual
204 (177, 234) 197 (168, 231) 201 (173, 232) 168 (145, 194)
Intercept 69.7 (46.4, 104.6) 64.6 (40.5, 103.1) 104.5 (76.7, 142.3) 124.4 (94.8, 163.4)
Time e 0.08 (0.03, 0.18) 0.04 (0.01, 0.15) 0.07 (0.03, 0.15)
* The intercept indicates the average score at baseline.
y Random effect.
z Fixed effect.
x Compared to BMI < 30 kg/m2.
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only, but the reasons for this are unclear. Themethods did not allow
us to grade the severity of cardiac disease at baseline, and
conceivably, patients undergoing THA could have more severe
cardiac disease than those undergoing TKA. Others have also
recognized that cardiac disease is more commonly reported in
obese patients undergoing THA than non-obese patients although
this was not reﬂected in a higher incidence of cardiac-related
complications49. The interaction between obesity and cardiac
disease was not signiﬁcant for pain or functional recovery. Diabetes
mellitus was not an independent factor, but the pattern of recovery
for diabetic patients was different than non-diabetic patients.
The impact of obesity on the recovery after TJA has remained
inconclusive due, in part, to contradictory ﬁndings in the literature.
Much of the vacillation can be attributed to methodological issues
such as deﬁning obesity. Obesity as deﬁned by BMI thresholds is
complex given age-related changes. The loss in height associated
with aging has ramiﬁcations on BMI which may lead to a misin-
terpretation of the degree of obesity. This facet has signiﬁcance for
men 50 years or older and women after 40 years in that BMI does
not measure the same degree of obesity for all ages50. The optimal
thresholds for BMI in older age cohorts remain contentious. The
effects of age-related changes on BMI in this older cohort were
recognized and themodels using BMI as a continuous variablewere
also examined to remove the predeﬁned class of obesity. Apart
from the changes in body mass associated with aging, inconsistent
BMI thresholds have been used in the literature to deﬁne morbid
obesity.
Obesity is a complex and challenging problem of which con-
founding effects of secondary pathologies should be evaluated to
clarify the true estimate of obesity on the recovery after TJA.
A strength of this study is that we examined the role of obesity on
the recovery of joint pain and function recovery in a community-
based cohort, with respect to potential associations and interac-
tions with cardiac disease and diabetes mellitus. In light of the
strengths of this study, there were limitations. We did not have
a full range of obesity, particularly Class 3, in THA patients. This may
be reﬂective of the distribution of obesity in the general populationor indicative of referral bias of the surgeons’ interpretation of
medical appropriateness for this elective surgery. Another limita-
tion is that we only examined obesity at time of surgery and did not
look at BMI over time. That being said, others have reported that
BMI and activity change little over the long-term recovery after
TJA36,51. We were also not able to assess the degree of severity of
diabetes or cardiac disease. Lastly, losses to follow-up is a factor that
may bias the results. It is likely that the effect of losses to follow-up
was minimal because the only systematic difference found con-
cerned baseline joint dysfunction, no other differences were seen
with demographic or medically-related factors. Moreover, the use
of a LM permitted the use of available data at each time period
unlike repeated measures analysis which is restricted to completed
sets of data.
Obesity is a risk factor for requiring a TJA11,12 and for recovery
after TJA. The ﬁndings from this study suggest that severe obesity is
an independent risk factor yet no interactions were seen among
obesity, diabetes mellitus and cardiac disease on recovery over
3 years. Long-term recovery of TJA for patients with severe obesity
is slower, in particular with achieving clinical functional improve-
ment. Given that obesity is a modiﬁable risk factor yet not easily
remedied, pre-and post-operative TJA management speciﬁcally
targeting obese patients should be developed. The challengewill be
to design effective multidisciplinary initiatives at all phases of
recovery for severely obese patients undergoing TJA.
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